Literature DB >> 816795

Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.

T Miyamoto, N Ogino, S Yamamoto, O Hayaishi.   

Abstract

The prostaglandin synthetase system of bovine vesicular gland microsomes was solubilized and separated into Fractions I and II. The former fraction catalyzed the conversion of 8,11,14-eicosatrienoic acid to prostaglandin H1 (9 alpha, 11alpha-epidioxy-15(S)-hydroxy-13-trans-prostenoic acid). This compound was isomerized to prostaglandin E1 (11alpha, 15(S)-dihydroxy-9-keto-13-trans-prostenoic acid) by the action of Fraction II (Miyamoto, T., Yamamoto, S., and Hayaishi, O. (1974) Proc. Natl. Acad. Sci. U.S.A. 71, 3645-3648). Fraction I was further purified by isoelectric focusing and about a 700-fold purification was achieved starting from the microsomes. When the enzyme was incubated with 8,11,14-eicosatrienoic acid in the presence of hematin, an unstable compound which was distinguishable from prostaglandin H1 accumulated. The chemical properties of this compound were identical with those of prostaglandin G1 (9 alpha, 11 alpha-epidioxy-15(S)-hydroperoxy-13-trans-prostenoic acid). The enzyme also catalyzed the conversion of prostaglandin G1 to H1 when heme and tryptophan were supplied. Thus, the purified enzyme, which was provisionally referred to as prostaglandin endoperoxide synthetase, exhibited two enzyme activities: the synthesis of prostaglandin G1 and its conversion to prostaglandin H1. Either free or protein-bound heme was required for both reactions, and only protoheme was active. Tryptophan stimulated the conversion of prostaglandin G1 to H1, and this stimulatory effect was also observed with various other aromatic compounds. Indomethacin and aspirin inhibited prostaglandin G1 synthesis, but not the other steps of prostaglandin biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816795

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

Review 1.  Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.

Authors:  David G Menter; Richard L Schilsky; Raymond N DuBois
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 2.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 3.  The role of nitric oxide in prostaglandin biology; update.

Authors:  Sangwon F Kim
Journal:  Nitric Oxide       Date:  2011-07-26       Impact factor: 4.427

Review 4.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

5.  Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  J Lipid Res       Date:  2008-07-26       Impact factor: 5.922

6.  The interaction between lipid peroxidation and prostaglandin synthesis in rabbit kidney-medulla slices.

Authors:  Y Fujimoto; H Tanioka; I Keshi; T Fujita
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

7.  Phospholipid actions on PGHS-1 and -2 cyclooxygenase kinetics.

Authors:  J Rand Doyen; Nur Yucer; Lenard M Lichtenberger; Richard J Kulmacz
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-12-08       Impact factor: 3.072

8.  The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells.

Authors:  Cornelia Czembirek; Christina Eder-Czembirek; Boban M Erovic; Dritan Turhani; Andreas Spittler; Edgar Selzer; Richard Pötter; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

9.  Immunocytochemical localization of prostaglandin endoperoxide synthase in the bovine intestine.

Authors:  K Ishimura; T Suzuki; K Fukui; A Yamamoto; Y Omoto; N Ueda; S Yamamoto
Journal:  Histochemistry       Date:  1993-06

10.  QSAR and conformational analysis of the antiinflammatory agent amfenac and analogues.

Authors:  J Ruiz; M López; J Milà; E Lozoya; J J Lozano; R Pouplana
Journal:  J Comput Aided Mol Des       Date:  1993-04       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.